Chlamydiae as pathogens--an overview of diagnostic techniques, clinical features, and therapy of human infections.
Chlamydiae are Gram-negative bacteria with obligate intracellular reproduction and disability to synthesize high-energy compounds such as ATP. Their cycle of development is unique among the prokaryotes: the host cells, mainly epithelial cells, are infected by so-called elementary bodies (EB) which undergo reorganization to form metabolically active reticulate bodies (RB). These RB multiply by binary fission, and after transition into infectious EB they are released within 48-72 hours. Chlamydiae cause prolonged subclinical infections of the conjunctiva, lung, cervix, and urethra. Complications in newborns are inclusion conjunctivitis, nasopharyngitis and pneumonia; in females, salpingitis, infertility, and perihepatitis; in male patients, epididymitis and prostatitis; and in both sexes, Chlamydiae-induced arthritis. Identification of the pathogenic agent confirms clinical diagnosis; tissue culture identification remains the diagnostic method of choice. Therapeutical drugs are tetracycline, erythromycin, josamycin, and in certain cases quinolone derivatives.
Institut für Medizinische Mikrobiologie, Westfälische Wilhelms-Universität Münster.
A
A
Oehme
P B
PB
Musholt
K
K
Dreesbach
D000818:Animals; D001170:Arthritis, Infectious / Q000382:microbiology; D002689:Chlamydia / Q000502:physiology*; D002690:Chlamydia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D003235:Conjunctivitis, Inclusion / Q000382:microbiology; D005260:Female; D005831:Genital Diseases, Female / Q000382:microbiology; D006801:Humans; D007231:Infant, Newborn; D008219:Lymphogranuloma Venereum / Q000382:microbiology; D011014:Pneumonia / Q000382:microbiology; D011247:Pregnancy; D009956:Psittacosis / Q000382:microbiology